Laboratory Current Deferred Revenue from 2010 to 2026
| LH Stock | USD 282.63 4.52 1.63% |
Current Deferred Revenue | First Reported 2007-12-31 | Previous Quarter 398 M | Current Value 391.6 M | Quarterly Volatility 342.4 M |
Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory's main balance sheet or income statement drivers, such as Interest Expense of 251.5 M, Total Revenue of 15.7 B or Gross Profit of 4.4 B, as well as many indicators such as Price To Sales Ratio of 1.6, Dividend Yield of 0.0138 or PTB Ratio of 3.26. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.
Laboratory | Current Deferred Revenue | Build AI portfolio with Laboratory Stock |
The Current Deferred Revenue trend for Laboratory of offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Laboratory is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Laboratory's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Laboratory of over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Laboratory's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Laboratory Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 275,630,088 | |
| Coefficient Of Variation | 80.43 | |
| Mean Deviation | 181,883,602 | |
| Median | 356,400,000 | |
| Standard Deviation | 221,676,075 | |
| Sample Variance | 49140.3T | |
| Range | 816.3M | |
| R-Value | 0.79 | |
| Mean Square Error | 19844.5T | |
| R-Squared | 0.62 | |
| Significance | 0.0002 | |
| Slope | 34,604,809 | |
| Total Sum of Squares | 786244.5T |
Laboratory Current Deferred Revenue History
About Laboratory Financial Statements
Investors use fundamental indicators, such as Laboratory's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Laboratory's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 451 M | 473.6 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Laboratory Correlation against competitors. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is there potential for Health Care Providers & Services market expansion? Will Laboratory introduce new products? Factors like these will boost the valuation of Laboratory. Expected growth trajectory for Laboratory significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.56 | Dividend Share 2.88 | Earnings Share 10.2 | Revenue Per Share | Quarterly Revenue Growth 0.086 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Laboratory's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Laboratory represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Laboratory's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.